|
 |
clopidogrel bisulfateThis page contains recent news articles, when available, and an overview of clopidogrel bisulfate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....legal battle over the blockbuster drug that began when Apotex applied for FDA approval to market a generic Plavix (clopidogrel bisulfate) in November 2001. FDA news (subscription) Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston ... - Nov 10, 2009 Over the next several years Sanofi is facing patent expirations on some of its biggest sellers, such as anti-clotting drug clopidogrel bisulfate (Plavix) ... Xconomy Supreme Court Declines Apotex Appeal Of Plavix Suit - Nov 2, 2009 Sanofi sued Apotex in 2002, shortly after the generics maker filed an abbreviated new drug application to market clopidogrel bisulfate, sold by Sanofi and ... IP Law360 (subscription) BristolMyers Squibb Company Reports Operating Results (10-Q) - Oct 22, 2009 PLAVIX* (clopidogrel bisulfate) and ABILIFY* (aripiprazole) continue to drive sales growth with sales increases of 8% and 16% for the three months ended ... GuruFocus.com Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009 - Oct 30, 2009 ...on Plavix®/Iscover® (clopidogrel bisulfate) and Aprovel®/Avapro®/Karvea® (irbesartan), based on information provided to us by our alliance partner. ... Reuters … New Indication for PLAVIX(R) (clopidogrel bisulfate) Offering New... - Aug 17, 2006 WHO SHOULD RECEIVE Plavix (clopidogrel bisulfate)? - Recent Myocardial Infarction (MI), Recent Stroke, or Established Peripheral Arterial Disease (PAD) For ... Free with registration - PR Newswire - AccessMyLibrary.com Bristol-Myers, Sanofi Win Trial, Block Generic Plavix - Jun 19, 2007 ...``Clopidogrel bisulfate satisfied a long-felt need for a better ... The earlier patent ``does not describe how to make clopidogrel bisulfate at all, ... Bloomberg … New Indication For Plavixо (clopidogrel Bisulfate) Offering New... - Aug 20, 2006 Administration (FDA) has approved the supplemental new drug application (sNDA) for the antiplatelet agent PLAVIXо (clopidogrel bisulfate) to reduce the ... Medical News Today - Medical News Today (press release) Bristol-Myers, Sanofi Trial Over Plavix Patent Ends in New York - Feb 15, 2007 Investors are betting Bristol-Myers and Sanofi will win the case, since the patent covers the main compound in Plavix, clopidogrel bisulfate. ... Bloomberg PLAVIX(R) (Clopidogrel Bisulfate) Recommended As Effective … - Dec 13, 2005 BRIDGEWATER, NJ, and PRINCETON, NJ, Dec. 13 /PRNewswire-FirstCall/ -- Recently, the American College of Cardiology (ACC) and the American Heart Association ... RedOrbit … Review to PLAVIX(R) (Clopidogrel Bisulfate) Supplemental New Drug ... - Jan 18, 2006 WHO SHOULD RECEIVE PLAVIX(R)(clopidogrel bisulfate)?(6). * Recent Myocardial Infarction (MI), Recent Stroke, or Established Peripheral Arterial Disease ... Free with registration - PR Newswire - AccessMyLibrary.com Bristol-Myers Q4 loss per share 0.07 usd - Jan 25, 2007 The company expects generic clopidogrel bisulfate that was sold into distribution channels following the Apotex at-risk launch in August 2006 will have a ... Forbes … Indication for PLAVIX(R) (clopidogrel bisulfate) Offering New... - Sep 7, 2006 ...(clopidogrel bisulfate) to include patients with ST-segment elevation acute myocardial infarction (STEMI) who are eligible for thrombolytic therapy. ... ots.at … Release: PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective... - Dec 13, 2005 PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective Cardiovascular Risk Reduction Treatment for Patients With Established Peripheral Arterial Disease ... Pay-Per-View - PR Newswire - HighBeam Research … New 300mg Loading Dose Tablet For PLAVIX(R) (clopidogrel Bisulfate) - Sep 28, 2007 Administration (FDA) has approved a supplemental new drug application (sNDA) for a 300mg tablet of the antiplatelet PLAVIX(R) (clopidogrel bisulfate). ... Medical News Today - Medical News Today (press release) Supreme Court of Canada redefines law on anticipation and obviousness... - Nov 24, 2008 The '777 patent is directed to clopidogrel bisulfate, which is an anti-coagulant marketed by Sanofi under the trade name Plavix. The '875 patent discloses a ... $9.94 - Mondaq Business Briefing - Alacra Store … Review To Plavix(R) (Clopidogrel Bisulfate) Supplemental New Drug ... - Jan 30, 2006 ...for the antiplatelet agent Plavix(R) (clopidogrel bisulfate) for treatment of patients with acute ST-segment elevation myocardial infarction (STEMI). ... Medical News Today - Medical News Today (press release) Preliminary Injunction Ordered In PLAVIX(R) Patent Infringement Case ... - Sep 2, 2006 ...("Apotex") to halt its sales of a generic version of clopidogrel bisulfate product that competes with PLAVIX(R). The Court, however, did not order Apotex to ... Medical News Today - Medical News Today (press release) Sanofi-Aventis Defends Plavix Patent at Canada's Highest Court - Apr 16, 2008 Apotex claims that clopidogrel bisulfate, the active ingredient, was covered by a patent that expired in 2003. Sanofi maintains that the earlier patent ... Bloomberg Plavix(R) Preliminary Injunction Appeal. - Sep 21, 2006 That injunction ordered Apotex to halt its sales of a generic version of clopidogrel bisulfate product that competes with PLAVIX(R). ... Free with registration - PR Newswire - AccessMyLibrary.com Canada, Intellectual Property, Supreme Court Of Canada Upholds … - Jul 11, 2008 The selection in this Sanofi case was clopidogrel bisulfate, marketed as Plavix. ... Apotex argued that the patent for clopidogrel bisulfate was invalid for ... Mondaq News Alerts - Mondaq News Alerts (Registration) Bristol-Myers Squibb Profits Up; Plavix Gets Credit - Aug 3, 2007 Supplies of generic clopidogrel bisulfate have been substantially depleted, which helped lift sales of the brand drug, the company said. FDA news - FDA news (subscription) Sanofi-Synthelabo v. Apotex, Inc., 470 F.3d 1368, 81 USPQ2d 1097... - Dec 8, 2006 The active ingredient in Plavix® is clopidogrel bisulfate, ... According to Apotex, claim 2 describes clopidogrel bisulfate and thus anticipates claim 3 of ... $2.95 - U.S. Court of Appeals, Federal Circuit - VersusLaw Loislaw Federal District Court Opinions - SANOFI-SYNTHELABO, INC. v. ... - Aug 31, 2005 The active ingredient of Plavix is clopidogrel bisulfate. (Id.) Sanofi obtained a patent claiming clopidogrel bisulfate on July 11, 1989, naming Sanofi ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Supreme Court Of Canada Upholds Selection Patents. - Nov 7, 2008 Facts The selection in this Sanofi case was clopidogrel bisulfate, ... The Court then considered the validity of the clopidogrel bisulfate patent in light ... $9.94 - Mondaq Business Briefing - Alacra Store Clopidogrel bisulfate 75-mg tablets.. - Sep 4, 2006 Clopidogrel bisulfate 75-mg tablets.. Apotex Corp., Weston, Fla., (800) 706-5575, is introducing clopidogrel bisulfate 75-mg tablets. ... $9.94 - Drug Topics - Alacra Store Clopidogrel bisulfate 75-mg tablets..(NEW GENERICS)(Brief article) - Sep 4, 2006 Apotex Corp., Weston, Fla., (800) 706-5575, is introducing clopidogrel bisulfate 75-mg tablets. The approval offers a generic alternative to Sanofi's Plavix ... $4.95 - Drug Topics - ECNext … New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)... - Sep 27, 2007 Article: PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ... PR Newswire; December 13, 2005 ; 700+ words ... ... guidelines, the antiplatelet ... Pay-Per-View - PR Newswire - HighBeam Research FDA Safety Labeling Changes: Plavix, Sustiva, Prevpac - Jul 13, 2005 Clopidogrel bisulfate tablets are indicated for the reduction of atherothrombotic events in patients with a history of recent myocardial infarction or ... Medscape … Review to PLAVIX(R) (clopidogrel bisulfate) Supplemental New Drug ... - Jan 18, 2006 FDA Grants Priority Review to PLAVIX(R) (clopidogrel bisulfate) Supplemental New Drug Application (sNDA) for Additional Type of Heart Attack. from PR ... Pay-Per-View - PR Newswire Europe - HighBeam Research Bristol-Myers Squibb Company Reports Financial Results for the Second... - Jul 26, 2007 Generic clopidogrel bisulfate in the distribution channels is substantially depleted as reflected in the second quarter results. ... Free with registration - PR Newswire - AccessMyLibrary.com … Review to PLAVIX(R) (Clopidogrel Bisulfate) Supplemental New Drug ... - Jan 18, 2006 FDA Grants Priority Review to PLAVIX(R) (Clopidogrel Bisulfate) Supplemental New Drug Application (sNDA) for Additional Type of Heart Attack. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Cogentus Pharmaceuticals Begins Clinical Study to … - Jan 16, 2008 Article: PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ... PR Newswire; December 13, 2005 ; 700+ words ... ... guidelines, the antiplatelet ... Pay-Per-View - PR Newswire - HighBeam Research Sanofi/B-MS prevail over US Plavix patent. - Jun 25, 2007 The US District Court for the Southern District of New York has upheld the validity and enforceability of US patent 4847265 covering clopidogrel bisulfate, ... $9.94 - Pharma Marketletter - Alacra Store … Indication for PLAVIX(R) (clopidogrel bisulfate) Offering New... - Sep 7, 2006 European Commission Expands Indication for PLAVIX(R) (clopidogrel bisulfate) Offering New Option for Patients With Most Severe Type of Heart Attack. from PR ... Pay-Per-View - PR Newswire Europe - HighBeam Research United States: Federal Circuit Affirms Preliminary Injunction To Halt... - May 1, 2007 On this basis alone, the Court found that clopidogrel bisulfate is not a species of any genus comprised by claim 2 of the '596 patent. ... Mondaq News Alerts - Mondaq News Alerts (Registration) United States Federal Circuit Court of Appeals Reports - SANOFI- … - Dec 12, 2008 Apotex, Inc. filed an Abbreviated New Drug Application (ANDA)[fn1] in November 2001 for FDA approval to sell clopidogrel bisulfate, stating, pursuant to 21 ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw Sanofi-aventis And BMS Announce Agreement To Settle US Plavix(R) … - Mar 26, 2006 The lawsuit relates to the validity of a composition of matter patent for clopidogrel bisulfate (the '265 patent), a medicine made available in the United ... Medical News Today - Medical News Today (press release) Federal Circuit Affirms Preliminary Injunction To Halt Generic Launch... - Jan 5, 2007 On this basis alone, the Court found that clopidogrel bisulfate is not a species of any genus comprised by claim 2 of the '596 patent. ... Free with registration - Mondaq Business Briefing - AccessMyLibrary.com Rationale and Design of CURRENT-OASIS 7 Study Published in … - Nov 6, 2008 Antiplatelet therapy with Plavix ® (clopidogrel bisulfate) and aspirin reduces major cardiovascular events in ACS patients during and after coronary ... International Business Times PLAVIX(R) Litigation Settlement Fails to Receive Antitrust Clearance ... - Jul 28, 2006 The lawsuit relates to the validity of a composition of matter patent for clopidogrel bisulfate (the '265 patent), a medicine made available in the United ... Genetic Engineering News - Genetic Engineering News (press release) Press Release: Plavix(R) Indications Expanded in Japan to Include … - Oct 22, 2007 WHO SHOULD RECEIVE PLAVIX(R)(clopidogrel bisulfate)?(6) PLAVIX is indicated for the reduction ... stroke, or established PAD, PLAVIX has been shown to ... Pay-Per-View - PR Newswire Europe - HighBeam Research Rationale and Design of CURRENT-OASIS 7 Study Published in … - Jun 11, 2008 Antiplatelet therapy with Plavix ® (clopidogrel bisulfate) and aspirin reduces major cardiovascular events in ACS patients during and after coronary ... FINANZEN.NET NEWS - FINANZEN.NET NEWS Canadian Federal Court of Appeals Rules in sanofi-aventis' Favor in... - Dec 28, 2006 Absent a Notice of Compliance, Apotex cannot market its 75mg clopidogrel bisulfate tablets in Canada. Sanofi-aventis is the world's third largest ... Free with registration - PR Newswire - AccessMyLibrary.com Sanofi-aventis and Bristol-Myers Squibb agree to settle patent... - Mar 21, 2006 The lawsuit relates to the validity of a composition of matter patent for clopidogrel bisulfate (the '265 patent), a medicine made available in the United ... News-Medical.net Acusphere Presents at Controlled Release Society - Jul 12, 2007 The reformulation of clopidogrel bisulfate is an example of the potential for ... "Clopidogrel bisulfate is a particularly challenging drug to formulate for ... Genetic Engineering News - Genetic Engineering News (press release) Bristol-Myers sees Plavix clone shortly. - Aug 8, 2006 ..."The company currently anticipates that generic clopidogrel bisulfate product will be ... Clopidogrel bisulfate is the active ingredient in Plavix. ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Sanofi-Aventis says generic Plavix launch by Dr. Reddy 'highly... - Jan 17, 2008 Dr. Reddy's received marketing approval from the US Food & Drug Administration for Clopidogrel Bisulfate, a generic version of Sanofi's blood-thinning drug ... MarketWatch Loislaw Federal District Court Opinions - SANOFI-SYNTHELABO v. … - Jun 19, 2007 The active ingredient of Plavix® is clopidogrel bisulfate. (Id.) Sanofi obtained a patent claiming clopidogrel bisulfate on July 11, 1989, naming Sanofi ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Plavix litigation settlement agreement amended. - Jun 1, 2006 Among other revisions, under the terms of the modified agreement, Apotex's license to manufacture and sell its FDA approved clopidogrel bisulfate product in ... $4.95 - BIOTECH Patent News - ECNext Global top 300 multisource generic pharmaceuticals by sales, … - Apr 28, 2008 Meloxicam 68180050201 101 Apotex Clopidogrel bisulfate 60505025301 102 Mylan Nifedipine ER 00378348201 103 Apotex Terbinafine HCI 60505257203 104 Danbury ... $20.00 - Chain Drug Review - Alacra Store Preliminary Injunction Ordered In Plavix(R) Patent Infringement Case;... - Sep 4, 2006 ...("Apotex") to halt its sales of a generic version of clopidogrel bisulfate product that competes with PLAVIX®. The Court, however, did not order Apotex to ... Lifescience-online Motion Filed For Preliminary Injunction In PLAVIX® Patent Infringement... - Aug 14, 2006 ...("Apotex") to halt its sales of a generic version of clopidogrel bisulfate product that competes with PLAVIX®. The motion was filed in the US District Court ... webwire.com Sanofi-Aventis says UK's Aircoat has abandoned effort to revoke... - Aug 5, 2005 ...has dropped its legal challenge seeking to revoke Sanofi's patent for clopidogrel bisulfate, the main ingredient of its Plavix blood-thinning drug. ... Forbes Press Release: Plavix(R) Indications Expanded in Japan to Include … - Oct 22, 2007 WHO SHOULD RECEIVE PLAVIX(R)(clopidogrel bisulfate)?(6) PLAVIX is indicated for the reduction ... stroke, or established PAD, PLAVIX has been shown to ... Pay-Per-View - PR Newswire - HighBeam Research Loislaw Federal District Court Opinions - SANOFI-SYNTHELABO v. … - Aug 31, 2006 The active ingredient of Plavix is clopidogrel bisulfate. (Id.) Sanofi obtained a patent claiming clopidogrel bisulfate on July 11, 1989, naming Sanofi ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Bristol-Myers falling profits caused by generic competition - Oct 27, 2006 The launch of generic clopidogrel bisulfate had a significant adverse effect on sales in the third quarter, which the company estimates to be in the range ... Pharmaceutical Business Review Merger and Acquisition Scenario - Nov 22, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere May Is Stroke Awareness Month. What Can You Do to Reduce Your Risk? - May 24, 2006 WHO SHOULD RECEIVE Plavix (clopidogrel bisulfate)?5. For patients with a history of recent ... 5 Plavix(R) (clopidogrel bisulfate) Prescribing Information. ... Free with registration - PR Newswire - AccessMyLibrary.com Preliminary Injunction Ordered in Plavix Patent - Mar 9, 2006 On August 8, 2006, Apotex announced that it had launched a generic version of clopidogrel bisulfate 75 mg tablets. The Court has ordered the companies to ... ag-IP-news Agency United States Federal Circuit Court of Appeals Reports - SANOFI- … - Jan 19, 2007 The active ingredient in Plavix® is clopidogrel bisulfate, which is covered by Sanofi's patent, US Patent 4847,-265 ("the `265 patent"), which will expire ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw Sanofi-aventis And Bristol-Myers Squibb Announce Agreement To Settle ... - Mar 23, 2006 The lawsuit relates to the validity of a composition of matter patent for clopidogrel bisulfate (the '265 patent), a medicine made available in the United ... chemie.de Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium); Apixaban ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) $250.00 - Revere Reports - Revere New Study Furthers Understanding of the Role of Dual Antiplatelet … - Mar 12, 2006 Clopidogrel bisulfate is a prescription antiplatelet medicine taken once a day that helps keep ... WHO SHOULD RECEIVE Plavix(R)(clopidogrel bisulfate)? ... RedOrbit Update on Plavix(R) Litigation Settlement - Jun 25, 2006 Among other revisions, under the terms of the modified agreement, Apotex's license to manufacture and sell its FDA approved clopidogrel bisulfate product in ... RedOrbit Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium); Apixaban ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) $250.00 - Revere Reports - Revere Court grants Sanofi-Aventis' request for order of prohibition in the ... - Mar 22, 2005 ...and Apotex Inc in relation to Apotex's 2003 application in Canada for a marketing authorisation for a generic version of clopidogrel bisulfate tablets. ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Press Release: Bristol-Myers Squibb Lowers 2006 Earnings Per Share … - Sep 1, 2006 ...("Apotex") announced that it was launching at risk in the United States a generic clopidogrel bisulfate product that competes with PLAVIX(R), ... Pay-Per-View - PR Newswire - HighBeam Research Article: Top 250 multisource generics.(RX/GENERIC DRUGS)(Statistical ... - Apr 23, 2007 Clopidogrel bisulfate$375133824.78 Prasco Labs Fexofenadine HCI $343789356.17 ... Clopidogrel bisulfate$278453278.92 Teva USA Simvastatin ... ... Pay-Per-View - Chain Drug Review - HighBeam Research Press Release: Bristol-Myers Squibb, Makers of Plavix, Face Injury … - Oct 31, 2006 ADMINISTRATION HAS APPROVED THE ANTIPLATELET AGENT PLAVIX(R) (CLOPIDOGREL BISULFATE) TO REDUCE ... STEINHUBL, UNIVERSITY OF KENTUCKY: "The new PLAVIX ... Pay-Per-View - PR Newswire - HighBeam Research Article: FDA Approves Expanded Use for Plavix - AP Online | HighBeam ... - Aug 17, 2006 Serious side effects of Plavix, also known as clopidogrel bisulfate, include bleeding and, rarely, low white blood cell counts and low platelet counts with ... Pay-Per-View - Associated Press/AP Online - HighBeam Research International Approvals: Alvesco, Plavix, Paromomycin Injection - Sep 18, 2006 On September 7, the European Commission approved a new indication for clopidogrel bisulfate ( Plavix 75-mg tablets, made by Sanofi-Aventis, Inc, ... Medscape International Approvals: NuvaRing, Remicade, Plavix - Jun 25, 2007 On June 5, Health Canada approved a new indication for clopidogrel bisulfate, 75-mg tablets (Plavix, Sanofi-Aventis, Inc), allowing its use to reduce the ... Medscape International Approvals: Levemir, Plavix, Celsentri - Oct 29, 2007 On October 22, the Japanese Ministry of Health, Labor, and Welfare (MHLW) approved a new indication for clopidogrel bisulfate tablets ( Plavix, ... Medscape First-Time Generic Approvals: Flexeril, Plavix, and AndroGel - Feb 21, 2006 On January 20, the FDA approved a first-time generic formulation of clopidogrel bisulfate 75-mg tablets (made by Apotex Corporation; brand name Plavix, ... Medscape Merger and Acquisition Scenario - Nov 29, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) $250.00 - Revere Reports - Revere Article: FDA Approves Expanded Use for Plavix - AP Online | HighBeam ... - Aug 17, 2006 Article: PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ... PR Newswire; December 13, 2005 ; 700+ words ... ... the guidelines. ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Pfizer and Sanofi battle challenges on patents - Sep 8, 2005 Sanofi has recently seen off a challenge in the UK after a Scottish company attempted to overturn the patent for clopidogrel bisulfate, the active compound ... Pharmafocus Plavix Facing Generic Challenge - Jan 24, 2006 Instead, the agency simply placed on its Web site, among all medication listings, the drug's generic name, clopidogrel bisulfate, the dosage strength and ... TheStreet.com - TheStreet.com (subscription) Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere GlaxoSmithKline PLC acquires Bristol-Myers Squibb Pakistan from... - Dec 22, 2008 Inhibitors Products: Plavix (Clopidogrel Bisulfate) Bristol Myers Squibb Co. ( BMY ) Products: Plavix (Clopidogrel…Products: #R-BH# (Sapropterin ... Pay-Per-View - deals - Alacra Store Press Release: Sanofi-Aventis and Bristol-Myers Squibb Prevail in... - Jun 19, 2007 The Court also ruled that Apotex's generic clopidogrel bisulfate infringes sanofi-aventis' patent, and has enjoined Apotex from marketing this product in ... Pay-Per-View - M2 Presswire - HighBeam Research United States top 250 generic drugs by retail sales and manufacturer... - Apr 23, 2007 Clopidogrel bisulfate $375133824.78 Prasco Labs Fexofenadine HCI ... Clopidogrel bisulfate $278453278.92 Teva USA Simvastatin $263718526.27 Teva USA ... $20.00 - Chain Drug Review - Alacra Store Press Release: New Study Furthers Understanding of the Role of Dual … - Mar 12, 2006 The primary end-point (cardiovascular death, heart attack, or stroke ... dose and standard-dose PLAVIX(R) (clopidogrel bisulfate ... ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Canadian Federal Court of Appeals Rules in sanofi- … - Dec 28, 2006 Absent a Notice of Compliance, Apotex cannot market its 75mg clopidogrel bisulfate tablets in Canada. About sanofi-aventis ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Motion Filed for Preliminary Injunction in PLAVIX(R) … - Aug 14, 2006 ...("Apotex") to halt its sales of a generic version of clopidogrel bisulfate product that competes with PLAVIX(R). The motion was filed in the U.S. District ... Pay-Per-View - PR Newswire - HighBeam Research Bristol-Myers Sees Generic Plavix Rival | Article from AP Online | … - Aug 8, 2006 ..."The company currently anticipates that generic clopidogrel bisulfate product will be ... Clopidogrel bisulfate is the active ingredient in Plavix. ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere Article: US court halts generic sale.(Apotex injunction)(Brief... - Sep 18, 2006 ...find Chemistry and Industry articles. At the end of August, the generic version of Plavix (clopidogrel bisulfate), the clot-preventing drug co-mar... Pay-Per-View - Chemistry and Industry - HighBeam Research Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere Press Release: Sanofi-Aventis and Bristol-Myers Squibb Prevail in US ... - Jun 19, 2007 The Court also ruled that Apotex's generic clopidogrel bisulfate infringes sanofi-aventis' patent, and has enjoined Apotex from marketing this product in ... Pay-Per-View - PR Newswire - HighBeam Research Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere Top 300 multisource generics by manufacturer and NDC11 number.(RX/ … - Apr 28, 2008 Meloxicam 68180050201 101Apotex Clopidogrel bisulfate 60505025301 102Mylan Nifedipine ER 00378348201 103Apotex Terbinafine HCI60505257203 104Danbury ... Pay-Per-View - Chain Drug Review - HighBeam Research Plavix litigation settlement agreement amended. | Article from... - Jun 1, 2006 Among other revisions, under the terms of the modified agreement, Apotex's license to manufacture and sell its FDA approved clopidogrel bisulfate product in ... Pay-Per-View - BIOTECH Patent News - HighBeam Research Merger and Acquisition Scenario - Sep 6, 2008 Plavix (Clopidogrel Bisulfate); Monopril (Fosinopril Sodium); Pravachol (Pravastatin Sodium) ... Plavix (Clopidogrel Bisulfate). Heart Failure (HF) ... $250.00 - Revere Reports - Revere Apotex est empêché de vendre le générique du Plavix - Dec 28, 2006 «En l'absence d'un avis de conformité, Apotex ne peut pas commercialiser ses comprimés de clopidogrel bisulfate 75 mg au Canada», soulignent les deux ... Canoë Press Release: New Drug Application Submitted to FDA for Centrally … - Jan 25, 2008 Article: FDA Grants Priority Review to PLAVIX(R) (clopidogrel bisulfate) ... PR Newswire Europe; January 18, 2006 ; 700+ words . ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: May Is Stroke Awareness Month. What Can You Do to … - May 24, 2006 Article: PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ... PR Newswire; December 13, 2005 ; 700+ words ... ... heart attack or stroke(1). ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: FDA Approves New Indication For Plavix Offering New … - Sep 8, 2006 Article: PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ... PR Newswire; December 13, 2005 ; 700+ words ... ... increased risk for a heart ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: FIRST-EVER GUIDELINES ISSUED FOR MANAGEMENT … - Mar 24, 2006 Article: PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ... PR Newswire; December 13, 2005 ; 700+ words ... ... increased risk for a heart ... Pay-Per-View - PR Newswire - HighBeam Research Schweizerhall says near generic Plavix launch - May 9, 2008 Dr. Reddy's (NYSE:RDY) received marketing approval from the US Food & Drug Administration for Clopidogrel Bisulfate. The French company cited a June 19 US ... MarketWatch New Details in Reported Secret Deal Over Generic Drug - Aug 18, 2006 Apotex began shipping its generic version of Plavix, known as clopidogrel bisulfate. The company has flooded the United States market with millions of ... New York Times |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |